|
🐜
|
ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Associa
8 auth.
R. Hendel,
D. Berman,
M. D. Di Carli,
P. Heidenreich,
R. Henkin,
P. Pellikka,
...
G. Pohost,
K. Williams
|
9 |
2009 |
9
🐜
|
|
🐜
|
Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality
10 auth.
A. Yan,
A. Shayne,
K. Brown,
Sandeep N. Gupta,
Carmen W S Chan,
T. Luu,
...
M. D. Di Carli,
H. Reynolds,
W. Stevenson,
R. Kwong
|
9 |
2006 |
9
🐜
|
|
🐢
|
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
11 auth.
V. Murthy,
M. Naya,
C. Foster,
J. Hainer,
M. Gaber,
Gilda Di Carli,
...
R. Blankstein,
S. Dorbala,
Arkadiusz Sitek,
M. Pencina,
M. D. Di Carli
|
9 |
2011 |
9
🐢
|
|
🐢
|
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
15 auth.
R. Blankstein,
M. Osborne,
M. Naya,
A. Waller,
C. Kim,
V. Murthy,
P. Kazemian,
R. Kwong,
M. Tokuda,
H. Skali,
...
R. Padera,
J. Hainer,
W. Stevenson,
S. Dorbala,
M. D. Di Carli
|
9 |
2012 |
9
🐢
|
|
🦁
|
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.
14 auth.
M. D. Di Carli,
M. Davidson,
Roderick Little,
S. Khanna,
F. V. Mody,
R. Brunken,
J. Czernin,
S. Rokhsar,
L. Stevenson,
H. Laks,
...
R. Hawkins,
H. Schelbert,
M. Phelps,
J. Maddahi
|
9 |
1994 |
9
🦁
|
|
🐜
|
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
28 auth.
K. Gould,
Nils P Johnson,
T. Bateman,
R. Beanlands,
F. M. Bengel,
Robert M. Bober,
P. Camici,
M. Cerqueira,
B. Chow,
M. D. Di Carli,
S. Dorbala,
H. Gewirtz,
R. Gropler,
P. Kaufmann,
P. Knaapen,
...
J. Knuuti,
M. Merhige,
K. Rentrop,
T. Ruddy,
H. Schelbert,
T. Schindler,
M. Schwaiger,
S. Sdringola,
J. Vitarello,
K. Williams,
D. Gordon,
V. Dilsizian,
J. Narula
|
9 |
2013 |
9
🐜
|
|
🐢
|
Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes
11 auth.
Venkatesh L Murthy,
M. Naya,
V. Taqueti,
C. Foster,
M. Gaber,
J. Hainer,
...
S. Dorbala,
R. Blankstein,
O. Rimoldi,
P. G. Camici,
M. D. Di Carli
|
8 |
2014 |
8
🐢
|
|
🐢
|
Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review.
V. Taqueti,
M. D. Di Carli
|
8 |
2018 |
8
🐢
|
|
🦁
|
Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
M. D. Di Carli,
J. Janisse,
G. Grunberger,
J. Ager
|
8 |
2003 |
8
🦁
|
|
🐢
|
Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus
9 auth.
V. Murthy,
M. Naya,
C. Foster,
M. Gaber,
J. Hainer,
J. Klein,
...
S. Dorbala,
R. Blankstein,
M. D. Di Carli
|
8 |
2012 |
8
🐢
|
|
🐢
|
Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
11 auth.
V. Taqueti,
S. Solomon,
A. Shah,
Akshay S. Desai,
J. Groarke,
M. Osborne,
...
J. Hainer,
C. Bibbo,
S. Dorbala,
R. Blankstein,
M. D. Di Carli
|
8 |
2018 |
8
🐢
|
|
🐢
|
Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization
9 auth.
V. Taqueti,
R. Hachamovitch,
V. Murthy,
M. Naya,
C. Foster,
J. Hainer,
...
S. Dorbala,
R. Blankstein,
M. D. Di Carli
|
8 |
2015 |
8
🐢
|
